Reckitt Benckiser Group plc
Company characteristics
| Assessed report publication year | |
|---|---|
| Financial year end | 31/12/22 |
| Sector | Consumer Staples |
| Head office | United Kingdom |
| Primary listing | London Stock Exchange |
| GBP market cap | 41,185,058,604 |
| Net profit margin | 16.25% |
| CEO tenure | 1 years |
| Employee count | 40,000 |
| FRF draft assessment response |
Reward scrutiny
| Living wage accredited | Living wage (calculation for operating regions) | ||
|---|---|---|---|
| Living hours accredited | Tax reporting (GRI 207) |
Remuneration policies
| Remuneration committee 100% independent | Remuneration committee discretion applied | ||
|---|---|---|---|
| Director from workforce | Trade union relations (disclosure) | ||
| Worker consultation on top pay (disclosure) | 80%+ shareholder support on pay |
Reward outcomes
| CEO total pay (GBP) | 3,036,090 | CEO total pay change | -49.12% |
|---|---|---|---|
| CEO pay ratio (to median employee) | 61:1 | Percentage point increase in maximum variable remuneration | — |
| Pension award parity between CEO and wider workforce | Pay of the next highest exec compared to CEO | 188.15% | |
| Gender pay gap (mean data) | UK Group: 26.4% Reckitt Benckiser Corporate Services Ltd: 26.8% RB Healthcare (UK) Ltd: -3.3% RB Healthcare Manufacturing: 1.4% Reckitt Benckiser Health Ltd: 20.7% | Gender pay (women % in top quartile) | — |
| Ethnicity pay gap (disclosure) | Total dividend (GBP) | 1,312,000,000 |